- CA$104.62bn
- CA$200.85bn
- CA$43.65bn
- 64
- 72
- 92
- 90
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 50,069 | 39,087 | 47,071 | 53,309 | 43,649 |
Cost of Revenue | |||||
Gross Profit | 18,606 | 18,211 | 18,474 | 20,822 | 22,189 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 41,809 | 33,481 | 39,377 | 47,055 | 34,998 |
Operating Profit | 8,260 | 5,606 | 7,694 | 6,254 | 8,651 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 7,535 | 4,190 | 7,729 | 4,542 | 7,879 |
Provision for Income Taxes | |||||
Net Income After Taxes | 5,827 | 3,416 | 6,314 | 2,938 | 6,058 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 5,705 | 3,363 | 6,189 | 3,003 | 6,191 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 5,322 | 2,983 | 5,816 | 2,589 | 5,839 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.07 | 2.78 | 2.86 | 1.9 | 2.99 |
Dividends per Share |